| Characteristic |
Overall, N = 136 |
IV, N = 91 |
PO, N = 45 |
p-value |
| out_vs_inpatient |
|
|
|
0.4 |
| |
19 (27%) |
9 (24%) |
10 (31%) |
|
| 0 |
37 (53%) |
23 (61%) |
14 (44%) |
|
| 1 |
14 (20%) |
6 (16%) |
8 (25%) |
|
| pre_hr |
73 (65, 80) |
73 (65, 80) |
74 (65, 80) |
>0.9 |
| pre_sbp |
136 (127, 148) |
136 (128, 146) |
136 (125, 148) |
0.8 |
| pre_dbp |
80 (74, 87) |
80 (73, 86) |
83 (75, 90) |
0.2 |
| rhythm |
|
|
|
<0.001 |
| |
8 (5.9%) |
0 (0%) |
8 (18%) |
|
| 0 |
117 (86%) |
82 (90%) |
35 (78%) |
|
| 1 |
6 (4.4%) |
5 (5.5%) |
1 (2.2%) |
|
| 2 |
5 (3.7%) |
4 (4.4%) |
1 (2.2%) |
|
| metoprolol_dose |
0 (0, 25) |
0 (0, 0) |
50 (25, 50) |
<0.001 |
| ivabridine_dose |
0.00 (0.00, 0.00) |
0.00 (0.00, 0.00) |
0.00 (0.00, 0.00) |
<0.001 |
| iv_metoprolol |
0.0 (0.0, 10.0) |
5.0 (0.0, 10.0) |
0.0 (0.0, 0.0) |
<0.001 |
| post_hr |
63 (57, 69) |
63 (58, 67) |
63 (56, 73) |
0.7 |
| post_hr_variability |
0.80 (0.00, 1.40) |
0.80 (0.00, 1.60) |
0.85 (0.00, 1.40) |
0.5 |
| post_sbp |
123 (113, 133) |
122 (114, 132) |
127 (112, 137) |
0.3 |
| post_dbp |
72 (68, 77) |
72 (68, 77) |
73 (69, 80) |
0.2 |
| age |
57 (49, 69) |
59 (46, 70) |
56 (50, 67) |
0.8 |
| bmi |
29 (25, 34) |
29 (25, 34) |
29 (25, 33) |
0.8 |
| dlp_m_gycm |
431 (280, 597) |
409 (279, 599) |
451 (301, 586) |
>0.9 |
| m_sv |
6.2 (3.9, 9.0) |
5.5 (3.9, 8.9) |
6.5 (4.6, 9.2) |
0.7 |
| protocol |
|
|
|
0.006 |
| |
8 (6.0%) |
0 (0%) |
8 (18%) |
|
| 1 |
20 (15%) |
14 (16%) |
6 (13%) |
|
| 2 |
51 (38%) |
35 (39%) |
16 (36%) |
|
| 3 |
4 (3.0%) |
2 (2.2%) |
2 (4.4%) |
|
| 4 |
5 (3.7%) |
4 (4.5%) |
1 (2.2%) |
|
| 5 |
27 (20%) |
18 (20%) |
9 (20%) |
|
| 6 |
7 (5.2%) |
6 (6.7%) |
1 (2.2%) |
|
| 7 |
7 (5.2%) |
5 (5.6%) |
2 (4.4%) |
|
| prospective |
5 (3.7%) |
5 (5.6%) |
0 (0%) |
|
| table_time_min |
26 (20, 32) |
30 (25, 34) |
20 (15, 22) |
<0.001 |
| repeat_study |
|
|
|
<0.001 |
| |
8 (6.0%) |
0 (0%) |
8 (18%) |
|
| 0 |
120 (90%) |
84 (94%) |
36 (80%) |
|
| 1 |
6 (4.5%) |
5 (5.6%) |
1 (2.2%) |
|
| side_effects |
|
|
|
<0.001 |
| |
8 (6.0%) |
0 (0%) |
8 (18%) |
|
| 0 |
126 (94%) |
89 (100%) |
37 (82%) |
|